Haeli Bio: The controlling subsidiary GORORISE's absorbable collagen membrane product has obtained registration in Indonesia.

MetaMuskRat · 2026-04-07T08:30:35+00:00

People's Financial News, April 7 — Haili Bio(603718) announced on April 7 that its subsidiary Ruisheng Bio submitted registration documents for Ruisheng Bio's GORORISE absorbable collagen membrane product to the Indonesian Ministry of Health( hereinafter referred to as "MOH") in December 2025. Recently, Ruisheng Bio received notification from MOH that its GORORISE absorbable collagen membrane product has been approved by MOH.

MetaMuskRat

2026-04-07 08:30:35

People’s Finance News, April 7: On April 7, Haili Biologics (603718) announced that its controlling subsidiary, Ruisheng Biologics, submitted registration and filing materials to the Ministry of Health of Indonesia (hereinafter referred to as “MOH”) for its Ruisheng Biologics GORORISE absorbable collagen membrane product in December 2025. Recently, Ruisheng Biologics received a notice from the MOH confirming that its GORORISE absorbable collagen membrane product has been approved by the MOH.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.